Callitas Health Inc.

Equities

MPHMF

CA13125C1068

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 08:35:17 01/03/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	+9,900.00%

2018	James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc	CI
2018	Callitas Health Inc. Announces Management Changes	CI

First Sahara Energy Inc. agreed to spin-off its mineral properties.

December 11, 2013 at 10:30 am IST

First Sahara Energy Inc. (DB:T3F) announced the spin off its mineral properties on December 11, 2013. The mineral properties will be transferred to a new company which will be publicly listed and its shares would be distributed to First Sahara's shareholders. The transaction is subject to regulatory and shareholder approval.

Latest news about Callitas Health Inc.

James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc	07/18/07	CI
Callitas Health Inc. Announces Management Changes	04/18/04	CI
M Pharmaceutical Inc. Appoints Gary Thompson as President and CEO	13/17/13	CI
M Pharmaceutical Inc. announced that it expects to receive CAD 0.7 million in funding	06/16/06	CI
M Pharmaceutical Inc. Appoints Brian Keane as Interim President and CEO	04/16/04	CI
M Pharmaceutical Inc. Announces Resignation of Mathew Lehman as President, CEO and from the Board of Directors	15/16/15	CI
M Pharmaceutical Inc. (DB:T3F1) cancelled the sale of Remaining Oil and Gas Assets.	19/16/19	CI
M Pharmaceutical, Inc. Announces Resignation of Martin Mintchev from the Board of Directors and as Chief Scientific Officer	16/15/16	CI
M Pharmaceutical Inc. (DB:T3F2) entered into letter of intent to acquire reformulated orlistat for weight loss from Chelatexx, LLC for CAD 1.30 million.	20/15/20	CI
M Pharmaceutical In Acquisition Talks	21/15/21	CI
M Pharmaceutical Inc. Announces Management Changes	19/15/19	CI
M Pharmaceutical Inc. to Open a Fully Owned Subsidiary in Sofia, Bulgaria	18/15/18	CI
Rishena Enters Into Manufacturing Supply Agreement for Production of Trimtec Gastric Stimulation Device	18/15/18	CI
M Pharmaceutical Inc. Appoints Oliver Frank Bathe to its Advisory Board	17/15/17	CI
M Pharmaceutical Inc. announced that it expects to receive CAD 0.35 million in funding.	07/15/07	CI
M Pharmaceutical Inc. (DB:T3F1) completed the acquisition of Trimtec Biomedical Inc.	26/15/26	CI
M Pharmaceutical Inc Appoints Dr. Michel Fattouche to Advisory Board	19/15/19	CI
M Pharmaceutical Inc. Appoints Orly Yadid-Pecht to its Advisory Board	17/15/17	CI
M Pharmaceutical Inc. Appoints Christopher Andrews to Board of Directors	14/15/14	CI
M Pharmaceutical Inc. (DB:T3F1) entered into an agreement to acquire Trimtec Biomedical Inc.	07/15/07	CI
Callitas Health Inc. Auditor Raises 'Going Concern' Doubt	29/15/29	CI
M Pharmaceutical Inc. Announces the Appointment of Dr. Martin Mintchev as President & Chief Executive Officer	14/15/14	CI
M Pharmaceutical Inc. (DB:T3F1) entered into an agreement to sell Remaining Oil and Gas Assets for CND 0.25 million.	19/15/19	CI
M Pharmaceutical Inc. (DB:T3F1) completed the acquisition of the intellectual property associated with the eMosquito device by the purchase of M Diagnostics Inc.	19/15/19	CI
M Pharmaceutical Inc. announced that it has received CAD 1.08 million in funding.	13/15/13	CI

Chart Callitas Health Inc.

Duration

Period

More charts

Company Profile

Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CALLITAS HEALTH INC.	+9,900.00%	4.53T
MODERNA, INC.	+67.53%	6.39TCr
IQVIA HOLDINGS INC.	-0.77%	4.18TCr
LONZA GROUP AG	+44.98%	4.07TCr
CELLTRION, INC.	-10.87%	2.71TCr
ICON PUBLIC LIMITED COMPANY	+13.30%	2.65TCr
ALNYLAM PHARMACEUTICALS, INC.	-22.79%	1.87TCr
BIO-TECHNE CORPORATION	+4.70%	1.27TCr
UNITED THERAPEUTICS CORPORATION	+24.10%	1.21TCr
MEDPACE HOLDINGS, INC.	+27.41%	1.21TCr

Other Biotechnology & Medical Research